R39OTN

Transmittal #
R39OTN
Subject

Change in Coding on Medicare Claims for Darbepoetin Alfa (trade name Aranesp) and Epoetin Alfa (trade name Epogen, EPO) For Treatment Of Anemia In End Stage Renal Disease (ESRD) Patients On Dialysis

Implementation Date
2004-01-05
CR #
2963
Provider Education
MM2963
Provider Education Release Date
2004-02-13
Publication #
100-20
Related CR Effective Date
2004-01-01
Related CR Release Date
2004-10-31
Transmittal Year
2004